Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
53M
-
Shares change
-
-13.8M
-
Total reported value, excl. options
-
$87M
-
Value change
-
-$69.1M
-
Put/Call ratio
-
2.76
-
Number of buys
-
65
-
Number of sells
-
-80
-
Price
-
$1.64
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2024
180 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q2 2024.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53M shares
of 92.2M outstanding shares and own 57.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.95M shares), VANGUARD GROUP INC (4.54M shares), BANK OF AMERICA CORP /DE/ (4.16M shares), PFM Health Sciences, LP (4.08M shares), DIMENSIONAL FUND ADVISORS LP (2.62M shares), Point72 Asset Management, L.P. (2.34M shares), Elmwood Wealth Management, Inc. (2.33M shares), GEODE CAPITAL MANAGEMENT, LLC (1.91M shares), Kynam Capital Management, LP (1.65M shares), and STATE STREET CORP (1.62M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.